Day One Biopharmaceuticals reported a successful third quarter in 2024, driven by strong demand for its cancer therapy OJEMDA, which achieved $20.1 million in net revenue—a 145% increase from ...
On a challenging Day1, Dhruv Jurel's fighting knock of 80 was the only highlight for India-A as they were bowled out for 161 by Australia-A. KL Rahul and the rest of the Indian top order had an ...